What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?

Cleveland Clinic Journal of Medicine

Volumn 69, Issue 3, 2002, Pages 259-262

  Majhail, Navneet S ^a   Lichtin, Alan E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMPHOTERICIN B; AMPICILLIN; CEFALOTIN; COTRIMOXAZOLE; DIAZOXIDE; DICLOFENAC; DIGOXIN; DRUG ANTIBODY; ETHAMBUTOL; FLUCONAZOLE; GLYCERYL TRINITRATE; GOLD; IBUPROFEN; INDINAVIR; LEVAMISOLE; METHYLDOPA; METICILLIN; MINOXIDIL; OXYTETRACYCLINE; PARACETAMOL; PIPERACILLIN; QUINIDINE; QUININE; RIFAMPICIN; SULFAFURAZOLE; SULINDAC; TOLMETIN; UNINDEXED DRUG; VANCOMYCIN;

ANAMNESIS; ARTICLE; BLOOD CELL COUNT; BLOOD SMEAR; BONE MARROW EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DRUG INDUCED DISEASE; HUMAN; THROMBOCYTOPENIA;

EID: 0036118481     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.69.3.259     Document Type: Article

References (9)

1. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology
2. Standardization of definitions and criteria of causality assessment of adverse drug reactions: Drug-induced cytopenia
3. Drug-induced thrombocytopenia: A systematic review of published case reports
4. Drug-induced thrombocytopenia: Clinical data on 309 cases and the effect of corticosteroid therapy
5. Clinical assessment of drug-induced disease
6. Allergic reactions to drugs and biologic agents
7. Drug-induced immune thrombocytopenia: An overview of pathogenesis
8. Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy
9. Drug-induced thrombocytopenia: An updated systematic review